Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Medical Treatment Better Than Brain Stenting in Preventing Stroke

By HospiMedica International staff writers
Posted on 29 Sep 2011
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received percutaneous transluminal angioplasty and stenting (PTAS) in addition to the medical treatment, according to a new study.

Researchers at University Hospitals (UH) Case Medical Center (Cleveland, OH, USA), the Medical University of South Carolina (Charleston, USA), and other institutions randomly assigned patients who suffered a recent transient ischemic attack (TIA) or stroke attributed to stenosis in a major intracranial artery to aggressive medical management alone, or to aggressive medical management plus PTAS. More...
The primary end point was stroke or death within 30 days after enrollment, or a revascularization procedure for the qualifying lesion during the follow-up period, or stroke in the territory of the qualifying artery beyond 30 days.

Enrollment in the study was stopped after 451 patients underwent randomization, because the 30-day rate of stroke or death was 14.7% in the PTAS group, compared to 5.8% in the medical-management group. Beyond 30 days, stroke in the same territory occurred in 13 patients in each group. Currently, the mean duration of the ongoing follow-up is one year. The probability of the occurrence of a primary end-point event over time differed significantly between the two treatment groups, with one-year rates of the primary end point of 20% in the PTAS group and 12.2% in the medical-management group. The results were published early online on September 15, 2011, in the New England Journal of Medicine (NEJM).

“For now, we are thrilled that the effect of a very aggressive patient care plan to address all of their risk factors and make lifestyle changes to healthier living have demonstrated a significant impact in preventing stroke, and this impact is significant in as early as one month,” said lead author professor of neurology Cathy Sila, MD, director of the stroke and cerebrovascular center in the UH Neurological Institute. “I think this is a major achievement. The stroke or transient ischemic attack is the 'warning shot across the bow' and we need to get into battle mode immediately.”

A stroke, previously known medically as a cerebrovascular accident (CVA), is the rapidly developing loss of brain function due to disturbance in the blood supply to the brain. This can be due to ischemia caused by thrombosis or arterial embolism, or as a result of intracranial hemorrhage. Consequently, the affected area of the brain is unable to function, which might result in an inability to move one or more limbs on one side of the body, inability to understand or formulate speech, or an inability to see one side of the visual field.

Related Links:

University Hospitals (UH) Case Medical Center
Medical University of South Carolina






Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.